Lincoln National Q3 2026 Revenue Tops Estimates at $5.48B, but EPS Misses at $1.72
Revenue of $5.48B vs. $4.97B expected and adjusted EPS of $1.72 vs. $1.96; revenue up 19% from a year earlier.
Lincoln National (LNC) posted mixed third-quarter 2026 results, with revenue above the estimate and adjusted EPS below it. Revenue was $5.48 billion, up 19% from a year earlier, above the $4.97 billion estimate, and adjusted EPS was $1.72, down 16% from a year earlier, below the $1.96 estimate.
Shares fell 6.8% in premarket trading as of 6:03 a.m. ET, to $38.77 from a $41.60 close.
Q3 2026 scorecard
| Parameters | Expected | Actual | Beat/Miss |
|---|---|---|---|
| Adjusted EPS | $1.96 | $1.72 | Miss by 12% |
| Revenue | $4.97B | $5.48B | Beat by 10% |
| Change | YoY | QoQ |
|---|---|---|
| Adjusted EPS | ▼ 16% | ▼ 23% |
| Revenue | ▲ 19% | ▲ 11% |
By our calculation, revenue was $511.2 million above the estimate and adjusted EPS was $0.24 below it. The QoQ column compares with the previous quarter's revenue of $4.93 billion and adjusted EPS of $2.24. The YoY column compares with $4.59 billion and $2.04 in the same quarter a year earlier.
Track record
- EPS record. Adjusted EPS beat the estimate in 7 of the last 8 reports, including this one.
- Revenue record. Revenue beat the estimate in 5 of the last 8 reports.
- Revenue trend. Revenue over the last 5 reports, oldest first: $4.59 billion, $4.89 billion, $5.31 billion, $4.93 billion and $5.48 billion.
What to watch
- Next-quarter estimates. Consensus calls for EPS of $2.07 and revenue of $4.98 billion next quarter, based on 7 analysts.
- Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 19% increase to $5.48 billion.
- Estimate record. Whether Lincoln National extends a record of beating EPS estimates in 7 of its last 8 reports.
- Related coverage. See our reports on Ingredion, Lemonade, LifeStance Health and Prestige Consumer Healthcare.
Sources: Results are from Lincoln National's Nov. 5, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Lincoln National's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.
Readers also read
Ingredion Misses Q3 2026 Estimates as Revenue Falls 1.3% to $1.79B
EarningsLemonade Beats Q3 2026 Estimates as Revenue Rises 73% to $336.1M
EarningsLifeStance Health Beats Q3 2026 Estimates as Revenue Rises 25% to $455.9M
EarningsPrestige Consumer Healthcare Beats Fiscal Q2 2027 Estimates as Revenue Rises 23% to $336.3M
MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.